[ÇÑÅõÁõ±Ç ÁøÈ«±¹] Á¦¾à/¹ÙÀÌ¿À µ¥Àϸ® ´º½º
¾È³çÇϼ¼¿ä ÇÑÅõÁõ±Ç Á¦¾à¹ÙÀÌ¿À ÁøÈ«±¹ÀÔ´Ï´Ù.
¢º️ÀüÀÏ ¹Ì±¹ ÁÖ¿ä À妽º
* ´Ù¿ì +0.4% S&P Á¦¾à -0.8% ³ª½º´Ú ¹ÙÀÌ¿À -0.2%
¢º️ÇØ¿Ü Peer ÀüÀÏ ÁÖ°¡
* ¼¿Æ®¸®¿Â °ü·Ã: Pfizer +0.7% J&J +0.2% Teva -2.2% Mylan -2.4%
* »ï¼º¹ÙÀÌ¿À °ü·Ã: Lonza +0% Merck +0.1% Roche -0.1% Amgen +0.2% Biogen +0.4%
* Çѹ̾àÇ° °ü·Ã: Sanofi -0.8% Spectrum -4.4%
* º¸Å彺: Allergan -0.7% Revance Therapeutic -3.6% Evolus -2.7%
* ±âŸ: Gilead Science -0.4% Regeneron -0.1% Abbvie -0.8% Celgene +0.5% Eli Lilly -0.1% CSL -3.2%
¢º️±¹³» À̽´
* ÄÚ¿À·Õ»ý¸í°úÇÐ, ¹Ý±âº¸°í¼ 'ÇÑÁ¤'¡¦°ü¸®Á¾¸ñ À§±â
* À¯ÇѾçÇà, º£¸µ°Å °è¾à±Ý '460¾ï' ³»³â±îÁö ºÐÇÒÀνÄ
* »óÀåÁ¦¾à, ¼öÀͼº 'Àû½ÅÈ£'¡¦À۳⺸´Ù 20% ÁÙ¾ú´Ù
* ¿¡À̺ñ¿Â, µ¿¹ÝÁø´Ü °áÇÕ ¡®c-Met Ç×¾ÏÁ¦¡¯ µµÀü
* Á¾±Ù´ç, ºÎÀ§º° ¸ÂÃã»ç¿ë È÷¾Ë·ç·Ð»ê ÇÊ·¯ 4Á¾ Ãâ½Ã
¢º️ÇØ¿Ü À̽´
* ¾ÏÁ¨-³ë¹ÙƼ½º, ¹Ì±¹¼ ¿£ºê·¼ ƯÇãÀüÀï 2¶ó¿îµå µ¹ÀÔ
* ³ë¹ÙƼ½º, ÆĹֿ¡ APDS Ä¡·áÁ¦ 'CDZ173' ±â¼úÀÌÀü
* µ¥½ÃÆä¶ó, À§Àå°ü±âÁúÁ¾¾ç 3»ó¼ '1Â÷Á¾°áÁ¡ PFS' ÃæÁ·
* Ú¸¶õµµ½º, ½Ã¸®ÁîB 6õ¸¸Ý× À¯Ä¡.."IBD ÀÓ»ó2»ó Áغñ"
|